XML 23 R7.htm IDEA: XBRL DOCUMENT v3.24.0.1
Consolidated Statements of Stockholders' Equity (Deficit) - USD ($)
$ in Thousands
Total
Common Stock
Additional Paid-in Capital
Accumulated Deficit
Accumulated Other Comprehensive Loss
Beginning balance (in shares) at Dec. 31, 2020   81,669,000      
Beginning balance at Dec. 31, 2020 $ 107,325 $ 8 $ 424,823 $ (317,506) $ 0
Increase (Decrease) in Stockholders' Equity [Roll Forward]          
Net loss (106,606)     (106,606)  
Other comprehensive loss, net of tax (259)       (259)
Stock-based compensation 15,631   15,631    
Stock-based compensation - earnout 22,961   22,961    
Issuance of common stock for acquisitions (in shares)   2,043,000      
Issuance of common stock for acquisitions 35,707 $ 1 35,706    
Contingent consideration for acquisitions 6,685   6,685    
Reclassification of earnout liability upon vesting 54,891   54,891    
Reclassification of private warrant liability upon exercise 31,730   31,730    
Vesting of restricted stock (in shares)   2,549,000      
Exercise of stock warrants (in shares)   11,521,000      
Exercise of stock warrants 126,769 $ 1 126,768    
Exercise of stock options (in shares)   1,701,000      
Exercise of stock options 4,326   4,326    
Income tax withholdings (in shares)   (1,521,000)      
Income tax withholdings (28,940)   (28,940)    
Capped call transactions (52,913)   (52,913)    
Transaction costs (262)   (262)    
Ending balance (in shares) at Dec. 31, 2021   97,962,000      
Ending balance at Dec. 31, 2021 217,045 $ 10 641,406 (424,112) (259)
Increase (Decrease) in Stockholders' Equity [Roll Forward]          
Net loss (156,559)     (156,559)  
Other comprehensive loss, net of tax (5,912)       (5,912)
Stock-based compensation 27,041   27,041    
Issuance of common stock for acquisitions (in shares)   629,000      
Issuance of common stock for acquisitions 3,552   3,552    
Contingent consideration for acquisitions 530   530    
Vesting of restricted stock (in shares)   2,145,000      
Exercise of stock options (in shares)   474,000      
Exercise of stock options 1,116   1,116    
Income tax withholdings (in shares)   (613,000)      
Income tax withholdings (3,108)   (3,108)    
Repurchases of common stock (in shares)   (2,389,000)      
Repurchases of common stock (4,352)     (4,352)  
Ending balance (in shares) at Dec. 31, 2022   98,206,000      
Ending balance at Dec. 31, 2022 79,353 $ 10 670,537 (585,023) (6,171)
Increase (Decrease) in Stockholders' Equity [Roll Forward]          
Net loss (133,933)     (133,933)  
Other comprehensive loss, net of tax 2,311       2,311
Stock-based compensation $ 20,709   20,709    
Vesting of restricted stock (in shares)   3,122,000      
Exercise of stock options (in shares) 20,000 20,000      
Exercise of stock options $ 26   26    
Income tax withholdings (in shares)   (841,000)      
Income tax withholdings (1,240)   (1,240)    
Repurchases of common stock (in shares)   (1,396,000)      
Repurchases of common stock (3,100)     (3,100)  
Cancellations of common stock (in shares)   (2,050,000)      
Proceeds from sale of common stock 191   191    
Ending balance (in shares) at Dec. 31, 2023   97,061,000      
Ending balance at Dec. 31, 2023 $ (35,683) $ 10 $ 690,223 $ (722,056) $ (3,860)